Cargando…

Facile Synthesis of a Pt(IV) Prodrug of Cisplatin and Its Intrinsically (195m)Pt Labeled Analog: A Step Closer to Cancer Theranostic

BACKGROUND, AIMS AND OBJECTIVES: Cisplatin is extensively used in chemotherapy for treatment of a broad range of cancers. But its undesired side reactions with biomolecules that lead to severe side effects especially on kidney and nervous system, are limiting its clinical utility. To reduce its side...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, K. Shitaljit, Vimalnath, K. V., Phadnis, Prasad P., Chakravarty, Rubel, Chakraborty, Sudipta, Dash, Ashutosh, Vatsa, Rajesh K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320819/ https://www.ncbi.nlm.nih.gov/pubmed/34385784 http://dx.doi.org/10.4103/ijnm.IJNM_188_20

Ejemplares similares

Bone tumor–targeted delivery of theranostic (195m)Pt-bisphosphonate complexes promotes killing of metastatic tumor cells
por: Nadar, R.A., et al.
Publicado: (2020)

(1)H and (195)Pt NMR prediction for inclusion compounds formed by cisplatin and oxidized carbon nanostructures
por: De Souza, Leonardo A., et al.
Publicado: (2020)

Encapsulation of Pt(iv) prodrugs within a Pt(ii) cage for drug delivery
por: Zheng, Yao-Rong, et al.
Publicado: (2015)

Pt(IV) Prodrugs with NSAIDs as Axial Ligands
por: Spector, Daniil, et al.
Publicado: (2021)

Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands
por: Li, Xuejiao, et al.
Publicado: (2018)

Recent Advances in Light-Controlled Activation of Pt(IV) Prodrugs
por: Spector, Daniil, et al.
Publicado: (2022)

A Pt(IV) Prodrug Combining Chlorambucil and Cisplatin: A Dual-Acting Weapon for Targeting DNA in Cancer Cells
por: Montagner, Diego, et al.
Publicado: (2018)

Biological activity of Pt(IV) prodrugs triggered by riboflavin-mediated bioorthogonal photocatalysis
por: Alonso-de Castro, Silvia, et al.
Publicado: (2018)

Riboflavin as a bioorthogonal photocatalyst for the activation of a Pt(IV) prodrug
por: Alonso-de Castro, Silvia, et al.
Publicado: (2017)

An intramolecular photoswitch can significantly promote photoactivation of Pt(iv) prodrugs
por: Deng, Zhiqin, et al.
Publicado: (2021)

GSH-sensitive Pt(IV) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancer
por: Huang, Hui, et al.
Publicado: (2019)

Au@Pt Core-Shell Nanoparticle Bioconjugates for the Therapy of HER2+ Breast Cancer and Hepatocellular Carcinoma. Model Studies on the Applicability of (193m)Pt and (195m)Pt Radionuclides in Auger Electron Therapy
por: Wawrowicz, Kamil, et al.
Publicado: (2021)

Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake?
por: Ravera, Mauro, et al.
Publicado: (2021)

Image-Guided Nanodelivery of Pt(IV) Prodrugs to GRP-Receptor Positive Tumors
por: Silva, Francisco, et al.
Publicado: (2023)

First Attempts of the Use of (195)Pt NMR of Phenylbenzothiazole Complexes as Spectroscopic Technique for the Cancer Diagnosis
por: Pereira, Bruna T. L., et al.
Publicado: (2019)

NF-κB hijacking theranostic Pt(ll) complex in cancer therapy
por: Zhu, Yingzhong, et al.
Publicado: (2019)

Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral Administration
por: Barbanente, Alessandra, et al.
Publicado: (2022)

Controlled sequential in situ self-assembly and disassembly of a fluorogenic cisplatin prodrug for cancer theranostics
por: Wen, Xidan, et al.
Publicado: (2023)

Gd(iii)–Pt(iv) theranostic contrast agents for tandem MR imaging and chemotherapy
por: Adams, Casey J., et al.
Publicado: (2020)

Ultrasmall PtMn nanoparticles as sensitive manganese release modulator for specificity cancer theranostics
por: Guan, Guoqiang, et al.
Publicado: (2023)

Influence of the Number of Axial Bexarotene Ligands on the Cytotoxicity of Pt(IV) Analogs of Oxaliplatin
por: Nosova, Yulia N., et al.
Publicado: (2017)

Structure elucidation and quantification of the reduction products of anticancer Pt(iv) prodrugs by electrochemistry/mass spectrometry (EC-MS)
por: Frensemeier, L. M., et al.
Publicado: (2018)

N-Heterocyclic Carbene Platinum(IV) as Metallodrug Candidates: Synthesis and (195)Pt NMR Chemical Shift Trend
por: Bouché, Mathilde, et al.
Publicado: (2020)

Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
por: Zheng, Yao-Rong, et al.
Publicado: (2014)

Photopolymerized 3D Printing Scaffolds with Pt(IV) Prodrug Initiator for Postsurgical Tumor Treatment
por: Zhang, Qingfei, et al.
Publicado: (2022)

The charge radii of $^{198}$Pt - $^{183}$Pt
por: Hilberath, T, et al.
Publicado: (1989)

Delta G from high pT events at SMC and high pT analysis at COMPASS
por: Kurek, K
Publicado: (2005)

Redox double-switch cancer theranostics through Pt(iv) functionalised manganese dioxide nanostructures
por: Brito, Beatriz, et al.
Publicado: (2023)

Pt and RhPt dendritic nanowires and their potential application as anodic catalysts for fuel cells
por: Kehoe, Daniel K., et al.
Publicado: (2019)

The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH(3)COO)Cl(2)(NH(3))(2)(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake
por: Gabano, Elisabetta, et al.
Publicado: (2022)

Comprehensive Vibrational Spectroscopic Investigation of trans,trans,trans-[Pt(N(3))(2)(OH)(2)(py)(2)], a Pt(IV) Diazido Anticancer Prodrug Candidate
por: Vernooij, Robbin R., et al.
Publicado: (2016)

Synthesis and Validation of a Bioinspired Catechol-Functionalized Pt(IV) Prodrug for Preclinical Intranasal Glioblastoma Treatment
por: Mao, Xiaoman, et al.
Publicado: (2022)

Pt(IV) prodrug initiated microparticles from microfluidics for tumor chemo-, photothermal and photodynamic combination therapy
por: Zhang, Qingfei, et al.
Publicado: (2022)

Microelectronics for particle physicists, pt.1-pt.2
por: Heijne, Erik H M, et al.
Publicado: (1990)

Shape transition between $^{187}$Pt and $^{185}$Pt
por: Bourgeois, C, et al.
Publicado: (1976)

Cyclodextrin Rotaxanes of Pt Complexes and Their Conversion to Pt Nanoparticles
por: Suzaki, Yuji, et al.
Publicado: (2020)

Novel monodisperse FePt nanocomposites for T2-weighted magnetic resonance imaging: biomedical theranostics applications
por: Chang, Zhi-Xuan, et al.
Publicado: (2021)

Electrocatalytic oxidation of ethanol at Pd, Pt, Pd/Pt and Pt/Pd nano particles supported on poly 1,8-diaminonaphthalene film in alkaline medium
por: Hassan, K. M., et al.
Publicado: (2018)

Thermodynamics of CuPt nanoalloys
por: Rossi, K., et al.
Publicado: (2018)

In Vitro Evaluation of No-Carrier-Added Radiolabeled Cisplatin ([(189, 191)Pt]cisplatin) Emitting Auger Electrons
por: Obata, Honoka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9lrbcmhqic5p72v35oh28ulgvl